SLIRP-OT1
Putative uncharacterized protein SLIRP-OT1
Also known as: CN178_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SLIRP-OT1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
122 residues, UniProt reviewed canonical sequence.
>Q8N769|SLIRP-OT1
1 MGREMKKTGT PRPFRIEDPN QQPTWHDQPE MGSHYFAQAG LELLGSSNPP ASASQSAGIT
61 GVSHCARPGE HDLNHTVFQV KDSTFLRHLE SDRPEFKSCL PPHFTEPSVS LSTSEGCEDA
121 MGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLIRP-OT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLIRP-OT1 as an antibody target. Whether an autoantibody or antibody against SLIRP-OT1 could matter depends on whether native SLIRP-OT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLIRP-OT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLIRP-OT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...